| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f5ff0148176bc5136234de0c5ee82ce |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B35-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B33-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-32 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B35-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B33-20 |
| filingDate |
1998-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a5a51dc640d2f4aef498d0a8fd24f26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_489461ae6e11d1be6dca1dcc40e1a046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09c41bc0e11fa15ada959b6f9b2d5abe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de52658164307878baff84622cf78a9 |
| publicationDate |
2003-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-505765-A |
| titleOfInvention |
Biomaterial compound, used in the natural bone remodelling process, comprising calcium, oxygen and phosphorous wherein at least one element is substituted |
| abstract |
Described is a synthetic biomaterial compound based on stabilised calcium phosphates and more particularly to the molecular, structural and physical characterisation of this compound. The compound comprises calcium, oxygen and phosphorous, wherein at least one of the elements is substituted with an element having an ionic radius of approximately 0.1 to 1.1 angstroms. The knowledge of the specific molecular and chemical properties of the compound allows for the development of several uses of the compound in various bone-related clinical conditions. |
| priorityDate |
1998-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |